The purpose of this study is to evaluate the safety of lenalidomide and to define the
maximum tolerated escalation dose level (MTEDL) when administered by a stepwise
dose-escalation schedule in subjects with relapsed or refractory B-cell CLL.
Minimum age: 18 Years.
Maximum age: N/A.
Gender(s): Both.
University of Schleswig Holstein, Director Medizinische Klinik II, Campus Kiel, Chemnitzstrasse 33, Kiel 24116, Germany
University of Ulm, Abteilung Innere Medizin III, Robert-Koch-Strasse 8, Ulm 89081, Germany
Clinica Ematologica- A.O.U. San Martino, Clinica Ematologica Dipartimento di Medicina Interna, Genova 16132, Italy
Hospital Clinic Provincial de Barcelona, Servicio de Hematología, Institute of Haematology and Oncology, Villaroel, 170, Barcelona 8036, Spain
Karolinska Universitetssjukhuset, Hematologiskt Centrum, Karolinska Universitetssjukhuset,, Stockholm 141 86, Sweden
St James's Institute of Oncology, Dept. of Haematology, Level 3, Bexley Wing, Beckett Street, Leeds LS9 7TF, United Kingdom
Bart's and the London NHS Trust, St. Bartholomew's Hospital, 7th Floor Gloucester House, Cancer Services, London EC1A 7BE, United Kingdom
Christie Hospital NHS Foundation Trust, Haematology and Transplant Unit,, Manchester M20 4BX, United Kingdom
Cross Cancer Institute, Edmonton, Alberta T6G 1Z2, Canada
Arizona Cancer Center, Tucson, Arizona 85724, United States
Charité, Campus Benjamin Franklin, Medizinische Klinik III, Hindenburgdamm 30, Berlin 12203, Germany
Alta Bates Summit Comprehensive Cancer Center, Berkeley, California 94704, United States
Desert Hematology Oncology Medical Group, Inc., Rancho Mirage, California 92270, United States
Baptist Cancer Institute, Jacksonville, Florida 32207, United States
Cancer & Blood Disease Center, Lecanto, Florida 34461, United States
Northwest Georgia Oncology Centers, PC., Wellstar Health System, Marietta, Georgia 30060, United States
Mountain States Tumor Institute, Boise, Idaho 83712, United States
Robert H. Lurie Comprehensive Cancer Center, Chicago, Illinois 60611, United States
University of Chicago Medical Center, Chicago, Illinois 60637-1470, United States
Indiana University Medical center, Indianapolis, Indiana 46202-5149, United States
Uniklinik Köln, Klinik I für Innere Medizin, Klinisches Studienzentrum Hämatologie, Bettenhaus Ebene 04, Raum 001/048, Kerpener Str. 62, Koln 50924, Germany
LSU Health Sciences Center, Feist-Weiller Cancer Center, Shreveport, Louisiana 71130, United States
Cancer Care Manitoba, Winnipeg, Manitoba R3E 0V9, Canada
Karmanos Cancer Institute/Wayne State University School of Medicine, Detroit, Michigan 48201, United States
Roswell Park Cancer Institute, Buffalo, New York 14263, United States
Weill Medical College of Cornell University, Division of Hematology & Oncology, New York, New York 10021, United States
SUNY Upstate Medical Center, Syracuse, New York 13210, United States
Wake Forest University School of Medicine, Winston-Salem, North Carolina 27157, United States
The Cleveland Clinic Foundation, Cleveland, Ohio 44195, United States
Juravinski Cancer Centre, Hamilton, Ontario L8V 5C2, Canada
London Helath Science Centre, London, Ontario N6C 6B5, Canada
Abington Hematology Oncology Assoc., Inc., Willow Grove, Pennsylvania 19090, United States
Saskatoon Cancer Centre, Saskatoon, Saskatchewan S7N 4H4, Canada
University of Texas MD Anderson Cancer Center, Houston, Texas 77030, United States
Swedish Cancer Institute, Seattle, Washington 98104, United States